Research Article
Symptoms and Severity of COVID-19 in Patients with Immune-Mediated Inflammatory Diseases: Experience of a University Medical Center
Table 11
Systemic glucocorticoid therapy of IMID patients at the time of survey.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
IMID: immune-mediated inflammatory disease; COVID-19: coronavirus disease 2019; ; †data obtained by 153 patients; ‡to facilitate calculations, all individual dosages were standardized by conversion to a prednisone equivalent [28]. |